1507 studies found for:    Open Studies | "Hypertension"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension
Conditions: Renal Artery Stenosis;   Hypertension, Renovascular
Intervention: Device: iCAST™ Rx Stent System
2 Unknown  Pharmacogenomics in Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension;   PAH WHO Group I
Interventions: Drug: Sitaxsentan;   Drug: Bosentan, Ambrisentan
3 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis;   Interstitial Lung Disease;   Pulmonary Hypertension
Intervention: Drug: sildenafil
4 Recruiting Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension
Interventions: Drug: Bardoxolone methyl;   Drug: Placebo
5 Unknown  Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension
Conditions: Pulmonary Hypertension;   Pulmonary Arterial Hypertension;   Cardiovascular Diseases;   Lung Diseases;   Tanshinone IIA Sulfonate
Interventions: Drug: 20 mg sildenafil citrate by mouth;   Drug: sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth
6 Unknown  Registry for Pulmonary Hypertension in China
Conditions: Pulmonary Arterial Hypertension;   Chronic Thromboembolic Pulmonary Hypertension;   Death
Intervention:
7 Not yet recruiting Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
Condition: Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Interventions: Drug: Placebo capsules;   Drug: Bardoxolone methyl capsules
8 Recruiting An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Patients With Exercise Induced Pulmonary Arterial Hypertension
Condition: Exercised Induced Pulmonary Arterial Hypertension
Intervention: Drug: ambrisentan
9 Unknown  Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
Conditions: Idiopathic Pulmonary Arterial Hypertension;   Primary Pulmonary Hypertension;   Pulmonary Arterial Hypertension;   Familial Primary Pulmonary Hypertension
Interventions: Drug: Diltiazem Hydrochloride;   Drug: Sugar Pill
10 Recruiting Spironolactone for Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Spironolactone;   Drug: Placebo
11 Recruiting Right Ventricular Metabolism in Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   Healthy
Intervention: Drug: 11C acetate
12 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis
Interventions: Drug: bosentan;   Other: No specific intervention
13 Unknown  Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Procedure: Resynchronization therapy of right ventricle
14 Recruiting Hormonal, Metabolic, and Signaling Interactions in PAH
Conditions: Idiopathic Pulmonary Arterial Hypertension;   Heritable Pulmonary Arterial Hypertension;   Scleroderma Associated Pulmonary Arterial Hypertension;   Appetite Suppressant Associate PAH
Intervention:
15 Not yet recruiting Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Nebulized ipratropium bromide;   Drug: Nebulized combination ipratropium bromide with salbutamol;   Drug: Nebulized Placebo
16 Recruiting Aerobic Exercise Training in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Other: Upper extremity aerobic exercise training;   Other: Alternative upper extremity exercises
17 Recruiting Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Condition: Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Interventions: Biological: Rituximab;   Other: Placebo
18 Unknown  Iron Deficiency In Pulmonary Hypertension
Condition: Idiopathic Pulmonary Arterial Hypertension
Intervention: Drug: Ferricarboxymaltose
19 Recruiting Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension
Conditions: Congenital Heart Disease;   Pulmonary Arterial Hypertension
Intervention: Drug: Sildenafil singly or in association with Bosentan
20 Recruiting The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Ambrisentan plus Spironolactone;   Drug: Ambrisentan plus Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years